Zhang Z - Search Results

1

DNA damage repair profiling of esophageal squamous cell carcinoma uncovers clinically relevant molecular subtypes with distinct prognoses and therapeutic vulnerabilities.

Zhao N, Zhang Z, Wang Q, Li L, Wei Z, Chen H, Zhou M, Liu Z, Su J. Zhao N, et al. Among authors: zhang z. EBioMedicine. 2023 Oct;96:104801. doi: 10.1016/j.ebiom.2023.104801. Epub 2023 Sep 17. EBioMedicine. 2023. PMID: 37725855 Free PMC article.

2

Recurrence-Associated Long Non-coding RNA Signature for Determining the Risk of Recurrence in Patients with Colon Cancer.

Zhou M, Hu L, Zhang Z, Wu N, Sun J, Su J. Zhou M, et al. Among authors: zhang z. Mol Ther Nucleic Acids. 2018 Sep 7;12:518-529. doi: 10.1016/j.omtn.2018.06.007. Epub 2018 Jun 26. Mol Ther Nucleic Acids. 2018. PMID: 30195788 Free PMC article.

3

Computational identification of mutator-derived lncRNA signatures of genome instability for improving the clinical outcome of cancers: a case study in breast cancer.

Bao S, Zhao H, Yuan J, Fan D, Zhang Z, Su J, Zhou M. Bao S, et al. Among authors: zhang z. Brief Bioinform. 2020 Sep 25;21(5):1742-1755. doi: 10.1093/bib/bbz118. Brief Bioinform. 2020. PMID: 31665214

4

The Circular RNome of Developmental Retina in Mice.

Chen XJ, Zhang ZC, Wang XY, Zhao HQ, Li ML, Ma Y, Ji YY, Zhang CJ, Wu KC, Xiang L, Sun LF, Zhou M, Jin ZB. Chen XJ, et al. Mol Ther Nucleic Acids. 2020 Mar 6;19:339-349. doi: 10.1016/j.omtn.2019.11.016. Epub 2019 Nov 26. Mol Ther Nucleic Acids. 2020. PMID: 31877410 Free PMC article.

5

Identification of tumor immune infiltration-associated lncRNAs for improving prognosis and immunotherapy response of patients with non-small cell lung cancer.

Sun J, Zhang Z, Bao S, Yan C, Hou P, Wu N, Su J, Xu L, Zhou M. Sun J, et al. Among authors: zhang z. J Immunother Cancer. 2020 Feb;8(1):e000110. doi: 10.1136/jitc-2019-000110. J Immunother Cancer. 2020. PMID: 32041817 Free PMC article.

6

Computational recognition of lncRNA signature of tumor-infiltrating B lymphocytes with potential implications in prognosis and immunotherapy of bladder cancer.

Zhou M, Zhang Z, Bao S, Hou P, Yan C, Su J, Sun J. Zhou M, et al. Among authors: zhang z. Brief Bioinform. 2021 May 20;22(3):bbaa047. doi: 10.1093/bib/bbaa047. Brief Bioinform. 2021. PMID: 32382761

7

Computational principles and practice for decoding immune contexture in the tumor microenvironment.

Zhang Z, Bao S, Yan C, Hou P, Zhou M, Sun J. Zhang Z, et al. Brief Bioinform. 2021 May 20;22(3):bbaa075. doi: 10.1093/bib/bbaa075. Brief Bioinform. 2021. PMID: 32496512

8

Computational Methods and Applications for Identifying Disease-Associated lncRNAs as Potential Biomarkers and Therapeutic Targets.

Yan C, Zhang Z, Bao S, Hou P, Zhou M, Xu C, Sun J. Yan C, et al. Among authors: zhang z. Mol Ther Nucleic Acids. 2020 Sep 4;21:156-171. doi: 10.1016/j.omtn.2020.05.018. Epub 2020 May 21. Mol Ther Nucleic Acids. 2020. PMID: 32585624 Free PMC article.

9

Pan-cancer characterization of lncRNA modifiers of immune microenvironment reveals clinically distinct de novo tumor subtypes.

Zhang Z, Yan C, Li K, Bao S, Li L, Chen L, Zhao J, Sun J, Zhou M. Zhang Z, et al. NPJ Genom Med. 2021 Jun 17;6(1):52. doi: 10.1038/s41525-021-00215-7. NPJ Genom Med. 2021. PMID: 34140519 Free PMC article.

10

The pan-cancer landscape of crosstalk between epithelial-mesenchymal transition and immune evasion relevant to prognosis and immunotherapy response.

Wang G, Xu D, Zhang Z, Li X, Shi J, Sun J, Liu HZ, Li X, Zhou M, Zheng T. Wang G, et al. Among authors: zhang z. NPJ Precis Oncol. 2021 Jun 22;5(1):56. doi: 10.1038/s41698-021-00200-4. NPJ Precis Oncol. 2021. PMID: 34158591 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

112,248 results

Search Page

Filters